Autolus Therapeutics PLC (AUTL)
4.19
+0.08
(+1.95%)
USD |
NASDAQ |
May 03, 16:00
4.185
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Free Cash Flow: -156.57M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -156.57M |
| September 30, 2023 | -145.46M |
| June 30, 2023 | -142.48M |
| March 31, 2023 | -133.39M |
| December 31, 2022 | -123.15M |
| September 30, 2022 | -118.69M |
| June 30, 2022 | -118.60M |
| March 31, 2022 | -123.28M |
| December 31, 2021 | -126.72M |
| Date | Value |
|---|---|
| September 30, 2021 | -149.18M |
| June 30, 2021 | -153.68M |
| March 31, 2021 | -145.01M |
| December 31, 2020 | -132.44M |
| September 30, 2020 | -134.42M |
| June 30, 2020 | -119.58M |
| March 31, 2020 | -112.98M |
| December 31, 2019 | -120.15M |
Free Cash Flow Range, Past 5 Years
-156.57M
Minimum
Dec 2023
-112.98M
Maximum
Mar 2020
-132.69M
Average
-132.44M
Median
Dec 2020
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics PLC | -145.76M |
| Biodexa Pharmaceuticals Plc | -8.842M |
| NuCana PLC | -33.49M |
| TC BioPharm (Holdings) PLC | -13.42M |
| Mereo BioPharma Group PLC | -21.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.83M |
| Cash from Investing (Quarterly) | -1.477M |
| Cash from Financing (Quarterly) | 0.023M |
| Free Cash Flow Per Share (Quarterly) | -0.1511 |
| Free Cash Flow Yield | -21.48% |